Residents with at least one psychotropic medication · older people in all long‐term care settings
Summary of findings table ‐ Organisational intervention showed no clear difference in residents with at least one psychotropic medication compared with usual care (moderate certainty).
1 finding from 1 review
Residents with at least one physical restraint · older people in all long‐term care settings
1 finding from 1 review
Serious adverse events ‐ not measured · older people in all long‐term care settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Treatment time: time for a single nebulised treatment (min) · children and adults with cystic fibrosis
1 finding from 1 review
Serum deposition Cmax · adults and children with cystic fibrosis
1 finding from 1 review
Adverse events · adults and children with cystic fibrosis
It is very uncertain whether summary of findings ‐ nebulisers for delivering tobramycin:… changes adverse events compared with VMT (very low certainty).
1 finding from 1 review
FEV1 (% predicted): mean change from baseline · adults and children with cystic fibrosis
1 finding from 1 review
Time to next exacerbation · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant satisfaction or preference · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment time nebulisation time (min) · children aged 6 ‐ 18 with cystic fibrosis
1 finding from 1 review
Quality of life · children aged 6 ‐ 18 with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serum deposition Cmax · children aged 6 ‐ 18 with cystic fibrosis
1 finding from 1 review
Adverse events · children aged 6 ‐ 18 with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 (% predicted): mean change from baseline · children aged 6 ‐ 18 with cystic fibrosis
1 finding from 1 review
Intervention not reported
Quality of life · children and adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to next exacerbation · children aged 6 ‐ 18 with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant satisfaction or preference · children aged 6 ‐ 18 with cystic fibrosis
It is very uncertain whether summary of findings ‐ nebulisers for delivering tobramycin:… changes participant satisfaction or preference Satisfaction scale compared with VMT and AAD (very low certainty).
1 finding from 1 review
Treatment time (min) · adults and children with cystic fibrosis
1 finding from 1 review
Quality of life · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serum deposition Cmax · adults and children with cystic fibrosis
1 finding from 1 review